AI use is expanding in dermatology, but experts caution that more research is needed to optimize AI’s functionality for patients with skin of color. AI is changing how clinicians care for their patients, but problems with the technology persist....
Dermatology
Authoritative medical articles, news, research, and guidelines pertaining to Dermatology Newsletter.
RELEVANT ARTICLES IN DERMATOLOGY
A Look at Skin Cancer Disparities for Sexual Minority Groups
A Look at Skin Cancer Disparities for Sexual Minority Groups
Lifetime skin cancer prevalence among sexual minority adults compared with heterosexual adults varied across racial and ethnic groups and sexual orientation.
Itch & Pain Are Major Components of Psoriatic Disease & Require Management
Itch & Pain Are Major Components of Psoriatic Disease & Require Management
At IFPA 2024, Prof. Adam Reich reviewed itch in psoriasis, while Dr. Anushka Irani discussed the connection between pain and psoriatic disease.
Advertisement
Managing Obesity & Fibromyalgia in Psoriatic Disease
Managing Obesity & Fibromyalgia in Psoriatic Disease
During the IFPA 2024, Prof. Philip Mease, MD, from the University of Washington, focused on obesity and fibromyalgia and their impact on psoriatic arthritis.
Advances in Psoriasis Treatment: Topical Therapies Show Promising Results
Advances in Psoriasis Treatment: Topical Therapies Show Promising Results
In new advances for psoriasis treatment, topical therapies and creams have shown increased developments for patients.
Using Advances in the Genetics of Psoriatic Disease to Better Predict Treatment Response
Using Advances in the Genetics of Psoriatic Disease to Better Predict Treatment Response
How immune processes influence psoriatic disease development, and how genetic analysis can help predict treatment responses to different therapies.
A Look at Skin Cancer Disparities for Sexual Minority Groups
A Look at Skin Cancer Disparities for Sexual Minority Groups
Lifetime skin cancer prevalence among sexual minority adults compared with heterosexual adults varied across racial and ethnic groups and sexual orientation.
Itch & Pain Are Major Components of Psoriatic Disease & Require Management
Itch & Pain Are Major Components of Psoriatic Disease & Require Management
At IFPA 2024, Prof. Adam Reich reviewed itch in psoriasis, while Dr. Anushka Irani discussed the connection between pain and psoriatic disease.
Managing Obesity & Fibromyalgia in Psoriatic Disease
Managing Obesity & Fibromyalgia in Psoriatic Disease
During the IFPA 2024, Prof. Philip Mease, MD, from the University of Washington, focused on obesity and fibromyalgia and their impact on psoriatic arthritis.
Advances in Psoriasis Treatment: Topical Therapies Show Promising Results
Advances in Psoriasis Treatment: Topical Therapies Show Promising Results
In new advances for psoriasis treatment, topical therapies and creams have shown increased developments for patients.
Using Advances in the Genetics of Psoriatic Disease to Better Predict Treatment Response
Using Advances in the Genetics of Psoriatic Disease to Better Predict Treatment Response
How immune processes influence psoriatic disease development, and how genetic analysis can help predict treatment responses to different therapies.
Advertisement
Chronic Spontaneous Urticaria
A collection of feature articles, study abstracts, and other resources all focused on chronic spontaneous urticaria (CSU).
Advertisement
Stop Physician Burnout: the Hidden Danger of AI Note Writing Software
Stop Physician Burnout: the Hidden Danger of AI Note Writing Software
AI note writing software offers physicians short-term stress relief, but physician stress may shift to employer demand for increased patient quotas.
Medications in Obesity Treatment: Types, Benefits, and Considerations
Medications in Obesity Treatment: Types, Benefits, and Considerations
Dr. Jill Bryson explains which medications can be beneficial when incorporated into an obesity treatment plan, and factors that determine medication use.
Drawing the Line When “Curbsiding”
Drawing the Line When “Curbsiding”
Dr. MedLaw discusses where the line between safely offering informal consultation, or "curbsiding," and taking on the liability of a consultation gets drawn.
CME / CE
Patients With Melanoma In Situ Have Increased, But Low, Risk for Mortality
This course discusses that melanoma in situ (MIS) is not a definite precursor to invasive melanoma. While a patient’s chance of dying from melanoma is elevated (albeit low in absolute terms), their overall survival is significantly higher than that of their peers without MIS.
PODCAST
Biomarker Testing and NSCLC, Part 1
Sep 04, 2024
The Influence of Nutrition on Sleep Patterns
Aug 21, 2024Advertisement
MORE STORIES IN DERMATOLOGY
FILTER ARTICLES BY:
Advertisement
PODCAST
Biomarker Testing and NSCLC, Part 1
Sep 04, 2024The Influence of Nutrition on Sleep Patterns
Aug 21, 2024CARTOONS
Elbowing In
Elbowing In
Medical cartoon in which man needs an elbow specialist, but meets Joint Chief of Staff.
Big Pill to Swallow
Big Pill to Swallow
Medical cartoon in which the pharmacist is giving the customer a prescription bottle containing one huge, once-a-year pill.
You Gonna Finish That?
You Gonna Finish That?
Medical cartoon by Jonny Hawkins about patient asking another patient about finishing IV bag.
BUSINESS OF MEDICINE
Drawing the Line When “Curbsiding”
Drawing the Line When “Curbsiding”
Dr. MedLaw discusses where the line between safely offering informal consultation, or "curbsiding," and taking on the liability of a consultation gets drawn.
How Cash-Based Healthcare May Benefit Both Patients and Physicians
How Cash-Based Healthcare May Benefit Both Patients and Physicians
Cash-based healthcare aims to provide all individuals with vital healthcare services, eliminating the burden of navigating insurance company requirements.
What the Re-Classification of Cannabis as a Schedule III Drug Means for Physicians
What the Re-Classification of Cannabis as a Schedule III Drug Means for Physicians
Physicians should educate themselves on the benefits of medical marijuana, recognizing that cannabis may soon be re-classified as a Schedule III drug.
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.